Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 57 Carcinoma, Non-Small-Cell Lung 29 Breast Neoplasms 18 Rectal Neoplasms 14 Ovarian Neoplasms 14 Carcinoma, Hepatocellular 10 Neoplasm Metastasis 9 Glioblastoma 9 Colonic Neoplasms 9 Carcinoma, Renal Cell 8 Uterine Cervical Neoplasms 7 Fallopian Tube Neoplasms 7 Brain Neoplasms 6 Neoplasms 5 Nasopharyngeal Carcinoma 5 Lung Neoplasms 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Liver Neoplasms 4 Inflammatory Breast Neoplasms 4 Colorectal Cancer Metastatic 4 Carcinoma, Ovarian Epithelial 4 Stomach Neoplasms 3 Pleural Effusion, Malignant 3 Meningeal Carcinomatosis 3 Melanoma 3 Kidney Neoplasms 3 Glioma 3 Non-squamous Non-small Cell Lung Cancer 2 Liver Metastasis Colon Cancer 2

Interventions

sodium thiosulfate 1 Therapeutics 1 Sorafenib 1 Psychiatric Rehabilitation 1 Ocoxin 1 Melphalan 1 Mannitol 1 Ifosfamide 1 ICE protocol 5 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms, Germ Cell and Embryonal × Bevacizumab × Clear all

NCT01966913 2019-02-19

TAXIFIII

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Unknown

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡